BI Asset Management Fondsmaeglerselskab A S Has $24.17 Million Stake in Colgate-Palmolive Company $CL

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

BI Asset Management Fondsmaeglerselskab A S trimmed its stake in Colgate-Palmolive Company (NYSE:CL - Free Report) by 33.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 257,963 shares of the company's stock after selling 131,057 shares during the period. BI Asset Management Fondsmaeglerselskab A S's holdings in Colgate-Palmolive were worth $24,171,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the stock. Vanguard Group Inc. grew its position in Colgate-Palmolive by 0.6% in the first quarter. Vanguard Group Inc. now owns 81,758,257 shares of the company's stock valued at $7,660,749,000 after acquiring an additional 455,198 shares during the period. Northern Trust Corp grew its position in Colgate-Palmolive by 11.7% in the fourth quarter. Northern Trust Corp now owns 9,497,819 shares of the company's stock valued at $863,447,000 after acquiring an additional 993,328 shares during the period. Goldman Sachs Group Inc. grew its position in Colgate-Palmolive by 34.5% in the first quarter. Goldman Sachs Group Inc. now owns 7,980,387 shares of the company's stock valued at $747,762,000 after acquiring an additional 2,045,191 shares during the period. Deutsche Bank AG boosted its stake in Colgate-Palmolive by 3.7% in the first quarter. Deutsche Bank AG now owns 7,176,598 shares of the company's stock worth $672,447,000 after purchasing an additional 253,604 shares in the last quarter. Finally, Invesco Ltd. boosted its stake in Colgate-Palmolive by 5.0% in the first quarter. Invesco Ltd. now owns 6,867,209 shares of the company's stock worth $643,458,000 after purchasing an additional 329,291 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Trading Down 0.6%

Shares of CL traded down $0.5010 during trading hours on Friday, hitting $85.7790. 4,087,413 shares of the stock traded hands, compared to its average volume of 5,056,872. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. Colgate-Palmolive Company has a 1-year low of $82.40 and a 1-year high of $109.30. The firm has a market capitalization of $69.33 billion, a PE ratio of 24.10, a price-to-earnings-growth ratio of 4.49 and a beta of 0.35. The business has a fifty day moving average of $87.60 and a 200-day moving average of $89.91.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings results on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.03. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The business had revenue of $5.11 billion for the quarter, compared to analyst estimates of $5.03 billion. During the same quarter in the prior year, the firm posted $0.91 earnings per share. The firm's revenue for the quarter was up 1.0% compared to the same quarter last year. Analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were paid a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.4%. The ex-dividend date of this dividend was Friday, July 18th. Colgate-Palmolive's dividend payout ratio is 58.43%.

Analyst Ratings Changes

A number of equities analysts have commented on CL shares. Wells Fargo & Company reduced their price objective on Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating on the stock in a research note on Monday, August 4th. UBS Group reduced their price objective on Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating on the stock in a research note on Thursday, July 17th. Wall Street Zen lowered Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Wednesday, May 7th. JPMorgan Chase & Co. reduced their price objective on Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating on the stock in a research note on Monday, August 4th. Finally, Morgan Stanley reduced their price objective on Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating on the stock in a research note on Monday, August 4th. Seven research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $98.92.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.